Poinciana Advisors Group’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$263K Buy
+2,543
New +$227K 0.2% 83
2026
Q1
Sell
-2,543
Closed -$202K 136
2025
Q4
$202K Buy
+2,543
New +$200K 0.16% 132
2025
Q3
Sell
-5,036
Closed -$347K 129
2025
Q2
$347K Buy
5,036
+1,704
+51% +$112K 0.31% 60
2025
Q1
$226K Buy
+3,332
New +$199K 0.23% 81

Other funds holding CVS

Poinciana Advisors Group's CVS Position: Q2 2026 in Review

Poinciana Advisors Group opened a new position in CVS Health (CVS) in Q2 2026: 2,543 shares worth $263K. The stake represents 0.2% of the portfolio and ranks #83 among its holdings. This is a return to the name: Poinciana Advisors Group previously reported a position in CVS as recently as Q4 2025.

Poinciana Advisors Group first reported a position in CVS in Q1 2025 and has held it in 4 quarters since. The position peaked at $347K in Q2 2025. 1,271 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Poinciana Advisors Group held 2,543 shares of CVS Health worth $263K as of Q2 2026.
  • CVS Health was a new Poinciana Advisors Group position in Q2 2026.
  • CVS Health made up 0.2% of Poinciana Advisors Group's portfolio in Q2 2026, its #83 holding.
  • Poinciana Advisors Group first reported a position in CVS Health in Q1 2025 and has held it in 4 quarters since.
  • Poinciana Advisors Group's CVS Health position peaked at $347K in Q2 2025.
  • 1,271 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Poinciana Advisors Group's 13F filing for Q2 2026, filed 28 Jul 2026.